Syndicated Report

ASCO 2019: Top Data and Developments

June 13, 2019

Research Objectives:

  • Capture areas of greatest excitement regarding data presented or developments that took place during the American Society of Clinical Oncology (ASCO) Annual Meeting, June 2019 in Chicago.

Method: MicroSurvey via InCrowd
Crowds: Oncologists and Hematology-Oncologists
Sample Size: n=80 physicians, each providing 3 separate mentions for a total of 240 unique data points
Fielding Period: 2 days immediately following conference close
Screening Criteria: Qualified respondents are US-based oncs and hem/oncs who: Attended the ASCO Annual Meeting held between May 31 – June 4, 2019 in Chicago, IL in person

One key finding:

  • ASCO 2019 attendees most commonly cited developments in Lung, Breast, and Prostate cancers as exciting developments at this year’s conference.

Download the full report now!

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.